Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

  • Presentation

Skinternal Medicine: An Update on Cutaneous Manifestations of Systemic Disease

Description

In this presentation by Andrea Matterall, an update on cutaneous manifestations of systemic disease is discussed, focusing on a complex case of a 49-year-old male patient suspected of leprosy due to his skin lesions. Initial biopsy showed lymphocyte-rich epithelioid granulomatous dermatitis, despite negative infectious stains and PCR for Mycobacterium leprae. The patient's lesions did not improve with multidrug therapy, raising the possibility of misdiagnosis. Subsequent investigations and literature review led to consideration of rubella virus as a possible cause of granulomatous dermatitis as it was found in other patients with similar presentations. Ultimately, rubella was confirmed through specific staining of the biopsy, revealing a previously underrecognized association between rubella virus and cutaneous granulomas, mainly in immunocompromised patients but also in some immunocompetent individuals. The presentation emphasizes the critical need for thorough diagnosis and consideration of rare infectious etiologies in dermatologic cases that do not respond to standard treatments. It highlights the importance of awareness and ongoing research in the field of dermatology regarding systemic diseases that manifest through the skin.

View more

Conclusions

  • The diagnosis of the presented case was challenging, potentially misdiagnosed as leprosy when it was in fact related to rubella virus-associated granulomas.
  • Negative PCR results for Mycobacterium leprae do not exclude tuberculosis leprosy, highlighting the limitations of current diagnostic methods.
  • Granulomas in the biopsy revealed a preference for diagnosing tuberculoid leprosy over sarcoidosis due to the nature of the immune response.
  • The presentation of cutaneous granulomas in immunocompetent individuals may relate to inborn errors of immunity, particularly following rubella vaccination.
  • About 60% of idiopathic granulomatous cases are associated with rubella virus, indicating a prevalence that necessitates further investigation in similar cases.
  • Effective management may rely on controlling the underlying immunodeficiency conditions, which can lead to resolution of skin lesions.
  • Current diagnostic methodologies for rubella virus granulomas necessitate advanced molecular techniques and are limited to select laboratories.
  • Gurung P, et al. Clinical Microbiol Infect;2019;25(11):1315-27.
  • Cheng X, et al. PLoS Negl Trop Dis. 2019;13(3):e0007284.
  • Rapini. Practical Dermatopathology. Elsevier. 2021.
  • Munday WR, et al. J Cutan Pathol. 2015;42(7):465-70.
  • Ball NJ, et al. J Cutan Pathol. 2004;31:160.
  • Ishak R, et al. Int J Dermatol. 2015;54:33.
  • Cardoso J, et al. J Eur Acad Dermatol Venereol. 2009;23:678.
  • Rodriguez G, et al. Int J Dermatol. 2016;55(12):1336-40.
  • Leonel Utino, et al. J Cutan Pathol. 2018;45(2):111-7.
  • Rashek Kazi MD, PhD | Viktoryia Kazlouskaya MD, PhD | Jonhan Ho MD | Arivarasan Karunamurthy MD
  • Gerzain Rodríguez1,2, MD, and Alejandra Téllez2, MD
  • Krupnick Al, et al. Mt Sinai J Med. 2001;68(4-5):326-30.
  • Zhang D, et al. J Am Acad Dermatol. 2024;90(1):111-21.
  • Matsumoto K, et al. J Clin Immunol. 2020;40:1187-90.
  • Leclerc-Mercier S, et al. J Eur Acad Dermatol Venereol. 2019;33:1412-20.
  • Perelygina L, et al. Curr Opin Allergy Clin Immunol. 2020;20:574-81.
  • Leung J, et al. J Clin Immunol. 2018;38:717-26.
  • Zengin HB, et al. Am J Dermatopathol. 2021;43:e267-72.
  • Bodemer C, et al. Clin Microbiol Infect. 2014;20(10):O656-63.
  • Gross M, et al. J Allergy Clin Immunol. 2022;149:388-99.
  • Neven B, et al. Clin Infect Dis. 2017;64(1):83-6.